Bryan W. Sherman

Gramercy Research Group (United States)United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index469citations13works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Receptor Mechanisms and Signaling(5), Glaucoma and retinal disorders(4), Flavonoids in Medical Research(4), Protein Kinase Regulation and GTPase Signaling(2), Neuropeptides and Animal Physiology(2)

Publications13 total

Journal of Ocular Pharmacology and Therapeutics·2017· 181 citedOpen Access
Bioorganic & Medicinal Chemistry Letters·2016· 104 citedOpen Access
IOP-lowering Efficacy And Tolerability Of AR-13324, A Dual Mechanism Kinase Inhibitor For The Treatment Of Glaucoma
2012· 3 cited
Discovery and SAR of a Class of Ocularly-active Compounds Displaying a Dual Mechanism of Activity for the Treatment of Glaucoma
2012· 5 cited
Discovery and in vitro SAR of AR-12286, a Potent Kinase Inhibitor for the Treatment of Glaucoma
2009· 8 cited
Journal of Medicinal Chemistry·2006· 41 citedOpen Access

Frequent Co-authors

Mitchell A. deLong(5), Casey Kopczynski(5), Cheng‐Wen Lin(4), Carmen Laethem(4), Jill M. Sturdivant(4), Stephen J. Hodson(4), Michael J. Bishop(4), Jason D. Speake(4), Frank Navas(4), Deanna T. Garrison(4), Eric C. Bigham(4), David L. Saussy(4), Paul E Irving(4), Jeffrey D. Yingling(3), David Uehling(3), David N. Deaton(3), Conrad L. Cowan(3), Geoff Heintzelman(3), Lori Moore(2), Susan M. Royalty(2)